Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine TAP block for analgesia after abdominal surgery
ACTRN12608000297325Phase 2Not yet recruiting
- Sponsor
- Dr Elizabeth Hessian
- Start
- Feb 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Dr Elizabeth Hessian. Primary endpoint: Cumulative morphine requirement at 48 hours. Planned start Feb 2009; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12608000297325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000297325.